Multi-modal optical tissue diagnostic system

• US 20030135122A1
• Filed: 01/08/2003
• Published: 07/17/2003
• Est. Priority Date: 12/12/1997
• Status: Abandoned Application

• Current Assignee: Spectro Incorporated (Spectro Scientific, Inc.)
• Original Assignee: Spectro Incorporated (Spectro Scientific, Inc.)
• Inventors: Agrawal, Anant, Faupel, Mark L., Harrell, Tim, Bambot, Shabbir B.
• Application Number:
  US10/337,687
• Publication Number:
  US 20030135122A1
• Time in Patent Office: Days
• US Class Current: 600/476
• CPC Class Codes: A61B 1/043 for fluorescence imaging
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/0091 for mammography
• CPC Class Codes: A61B 5/4312 Breast evaluation or disorder diagnosis A61B5/0091 takes precedence
• CPC Class Codes: A61B 5/7264 Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems neural networks per se G06N3/00; expert systems per se G06N5/00

Abstract

An apparatus and method according to the invention combine more than one optical modality (spectroscopic method), including but not limited to fluorescence, absorption, reflectance, polarization anisotropy, and phase modulation, to decouple morphological and biochemical changes associated with tissue changes due to disease, and thus to provide an accurate diagnosis of the tissue condition.

Claims

1. A method for diagnosing a condition of a target tissue, comprising the steps of:

a.) irradiating a target tissue with excitation electromagnetic radiation;

b.) sensing a returned electromagnetic radiation returned from the target tissue;

c.) determining characteristics of the returned electromagnetic radiation using at least two spectroscopic methods;

d.) combining the characteristics determined by the at least two spectroscopic methods, thereby decoupling and detecting biochemical changes and morphological changes in the target tissue; and

e.) determining a condition of the target tissue based on the combined determined characteristics.

2. The method of claim 1, wherein the at least two spectroscopic methods comprise fluorescence measurements and scattering or reflectance measurements.

3. The method of claim 1, wherein the at least two spectroscopic methods are selected from the group consisting of absorption measurements, scattering measurements, reflection measurements, polarization anisotropic measurements, steady state fluorescence measurements, and time resolved fluorescence measurements.

4. The method of claim 3, wherein the time resolved fluorescence measurements comprise at least one of phase modulation techniques, polarization anisotropic techniques and techniques that directly monitor the decay profile of fluorescent emissions.

5. The method of claim 1, wherein step b.) comprises simultaneously sensing electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and excitation electromagnetic radiation that is scattered from the target tissue.

6. The method of claim 5, wherein step c.) comprises making intensity based measurements on both said electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and said excitation electromagnetic radiation that is scattered from the target tissue.

7. The method of claim 1, wherein step b.) comprises sensing electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and then subsequently sensing excitation electromagnetic radiation that is scattered from the target tissue.

8. The method according to claim 7, wherein a critical timing window, which is defined as the time period between sensing electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and subsequently sensing excitation electromagnetic radiation that is scattered from the target tissue, is not greater than approximately 0.25 seconds.

9. The method of claim 7, wherein step c.) comprises making intensity based measurements on both said electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and said excitation electromagnetic radiation that is scattered from the target tissue.

10. The method of claim 1, wherein step b.) comprises sensing approximately simultaneously electromagnetic radiation returned from a plurality of interrogation points distributed over the target tissue.

11. The method according to claim 10, further comprising a step of dividing the target tissue into a first set of field areas, wherein step c.) comprises determining characteristics of the returned electromagnetic radiation in each of said first set of field areas using at least two spectroscopic methods, step d.) comprises combining the characteristics determined by the at least two spectroscopic methods for each of said first set of field areas and step e.) comprises determining a condition of the target tissue by comparing the combined determined characteristics of each of said first set of field areas.

12. The method according to claim 11, further comprising a step of identifying visual characteristics of the target tissue, wherein the field areas are selected based on the identified visual characteristics of the target tissue.

13. The method according to claim 11, wherein the field areas are selected based on previously identified characteristics of the target tissue.

14. The method according to claim 13, wherein the previously identified characteristics of the target tissue comprise characteristics of the target tissue identified through previous testing of the target tissue using at least one of cytology, colposcopy and histopathology.

15. The method of claim 11, further comprising, after determining a condition of the target tissue by comparing the combined determined characteristics of each of said first set of field areas, re-dividing the target tissue into a second set of field areas, different from said first set of field areas and the determining characteristics of the returned electromagnetic radiation in each of said second set of field areas using at least two spectroscopic methods, combining the characteristics determined by the at least two spectroscopic methods for each of said second set of field areas and determining a condition of the target tissue by comparing the combined determined characteristics of each of said second set of field areas.

16. The method of claim 10, wherein the method is performed using an apparatus comprising an irradiation source, a detector and a processor, wherein the step of sensing electromagnetic radiation returned from a plurality of interrogation points comprises the steps of:

sensing electromagnetic radiation returned from the target tissue from a first subset of the plurality of interrogation points;

moving at least one of the apparatus and the tissue;

sensing electromagnetic radiation returned from the target tissue from a second subset of the plurality of interrogation points;

again moving at least one of the apparatus and the tissue; and

continuing this process until sensing has been performed at all of the plurality of interrogation points.

17. The method of claim 1, further comprising a step of generating a map of conditions of different portions of the target tissue based on the combined determined characteristics.

18. The method of claim 1, further comprising a step of conducting a pattern recognition process to determine whether a pattern of conditions exists within the target tissue.

38. The method according to claim 1, wherein step c) comprises taking fluorescence and scattering or reflective measurements at two wavelengths at each of a plurality of interrogation points;

step d) comprises determining a fluorescence ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points and averaging the fluorescence ratios and determining a scattering or reflectance ratio for the measurements taken at the two wavelengths at each of the plurality of interrogated points and averaging the scattering or reflectance ratios; and

step e) comprises determining a condition of the target tissue based on the averaged fluorescence and scattering or reflectance ratios.

39. The method of claim 38, wherein the step of determining a condition of the target tissue comprises plotting a point using the averaged fluorescence and scattering or reflectance ratio, a position of the plotted point being indicative of a condition of the target tissue.

40. The method of claim 38, wherein the target tissue is divided into quadrants and the plurality of interrogation points are distributed over a respective quadrant.

41. The method of claim 40, wherein the steps of claim 38 are repeated for each quadrant.

42. The method of claim 38, wherein the plurality of interrogation points are distributed over the surface area of the target tissue.

43. The method of claim 38, wherein the target tissue is divided into a plurality of field areas and the plurality of interrogation points are distributed over a respective field area.

44. The method of 43, wherein the steps of claim 38 are repeated for each of the plurality of field areas.

45. The method of claim 39, wherein step e) further comprises comparing the plotted point to plotted points representative of other target tissue.

46. The method of claim 45, wherein the other target tissue comprises target tissue belonging to other patients.

47. The method of claim 1, wherein step c) comprises taking fluorescence and scattering or reflectance measurements at two wavelengths at each of a plurality of interrogation points;

step d) comprises determining a fluorescence ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points, averaging the fluorescence ratios, determining a coefficient of variation value for the averaged fluorescence ratio, determining a scattering or reflectance ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points, averaging the scattering or reflectance ratios, determining a coefficient of variation value for the averaged scattering or reflectance ratio; and

step e) comprises determining a condition of the target tissue based on the coefficient of variation values.

48. The method according to claim 47, wherein the step of determining a condition of the target tissue comprises plotting a point using the coefficient of variation values, a position of the plotted point being indicative of a condition of the target tissue.

49. The method of claim 47, wherein the target tissue is divided into quadrants and the plurality of interrogation points are distributed over a respective quadrant.

50. The method of claim 49, wherein the steps of claim 45 are repeated for each quadrant.

51. The method of claim 47, wherein the plurality of interrogation points are distributed over the surface area of the target tissue.

52. The method of claim 47, wherein the target tissue is divided into a plurality of field areas and the plurality of interrogation points are distributed over a respective field area.

53. The method of 52, wherein the steps of claim 45 are repeated for each of the plurality of field areas.

54. The method of claim 48, wherein step e) further comprises comparing the plotted point to plotted points representative of other target tissue.

55. The method of claim 54, wherein the other target tissue comprises target tissue belonging to other patients.

56. The method of claim 1, further comprising mapping the characteristics determined by the at least two spectroscopic methods using false color mapping, wherein step e) comprises identifying abnormal tissue using the false color map.

57. The method of claim 1, wherein a multi-modal hyperspectral imaging camera is used to implement the method.

64. The system of claim 63, wherein the processor repeats the functions of claim 56 for each of the plurality of field areas.

74. The method according to claim 1, wherein step c) comprises taking fluorescence and scattering or reflective measurements at two wavelengths at each of a plurality of interrogation points;

step d) comprises determining a fluorescence to scattering or reflectance ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points and averaging the fluorescence to scattering or reflectance ratios; and

step e) comprises determining a condition of the target tissue based on the averaged fluorescence to scattering or reflectance ratio.

75. The method according to claim 1, wherein step c) comprises taking fluorescence and scattering or reflective measurements at two wavelengths at each of a plurality of interrogation points;

step d) comprises using one or more statistical method to analyze the fluorescence and scattering or reflective measurements; and

step e) comprises determining a condition of the target tissue based on the results of the statistical analysis.

76. The method of claim 75, wherein the statistical method is a measure of central tendency.

77. The method of claim 75, wherein the statistical method is a measure of variance.

78. The method of claim 75, wherein the statistical results obtained from a first portion of the target tissue is compared to the statistical results obtained from a second portion of the target tissue.

79. The method of claim 1, wherein the step of determining a condition of the target tissue based on the combined determined characteristics comprises determining whether the target tissue shows signs of dysplasia or metaplasia.

19. A system for determining a condition of a target tissue in a human or animal, comprising:

a electromagnetic radiation source for providing excitation electromagnetic radiation;

a device that couples the excitation electromagnetic radiation to a target tissue;

a device that senses electromagnetic radiation returned from the target tissue;

a processor configured to determine characteristics of the returned electromagnetic radiation using at least two spectroscopic methods, wherein the processor combines the characteristics determined by each of the at least two spectroscopic methods in order to decouple and detect biochemical changes and morphological changes in the target tissue and determines a condition of the target tissue based on the combined determined characteristics.

20. The system of claim 19, wherein the at least two spectroscopic methods comprise fluorescence measurement methods and scattering or reflectance measurement methods.

21. The system of claim 19, wherein the at least two spectroscopic methods are selected from the group consisting of absorption measurements, scattering measurements, reflectance measurements, polarization anisotropy measurements, steady state fluorescence measurements and time resolved fluorescence measurements.

22. The system of claim 19, wherein the device that senses returned electromagnetic radiation is configured to simultaneously sense fluorescent radiation emitted by endogenous fluorophores in response to the excitation radiation and excitation electromagnetic radiation that is scattered from the target tissue.

23. The system of claim 22, wherein the processor makes intensity based measurements on both said fluorescent radiation emitted by endogenous fluorophores in response to the excitation radiation and said excitation electromagnetic radiation that is scattered from the target tissue.

24. The system of claim 19, wherein the device that senses electromagnetic radiation is configured to first sense fluorescent radiation emitted by fluorophores in response to the excitation radiation and then subsequently sense excitation electromagnetic radiation that is scattered from the target tissue.

25. The system according to claim 24, wherein a critical timing window, which is defined as the time period between sensing electromagnetic radiation emitted from the target tissue in response to the excitation electromagnetic radiation and subsequently sensing excitation electromagnetic radiation that is scattered from the target tissue, is not greater than approximately 0.25 seconds.

26. The system of claim 24, wherein the processor makes intensity based measurements on both said fluorescent radiation emitted by endogenous fluorophores in response to the excitation radiation and said excitation electromagnetic radiation that is scattered from the target tissue.

27. The system of claim 19, wherein the device that senses electromagnetic radiation is configured to sense approximately simultaneously electromagnetic radiation returned from a plurality of interrogation points distributed over the target tissue.

28. The system according to claim 27, wherein the processor divides the target tissue into a first set of field areas, determines characteristics of the returned electromagnetic radiation in each of said first set of field areas using said at least two spectroscopic methods, combines the characteristics determined by each of said at least two spectroscopic methods for each of said first set of field areas and determines a condition of the target tissue in each of said first set of field areas based on the combined determined characteristics of the respective field areas.

29. The system according to claim 28, wherein the target tissue is divided into field areas according to previously identified characteristics of the target tissue.

30. The system according to claim 29, wherein the previously identified characteristics of the target tissue are visually identified characteristics of the target tissue.

31. The system according to claim 29, wherein the previously identified characteristics of the target tissue are characteristics of the target tissue identified through previous testing of the target tissue using at least one of cytology, colposcopy and histopathology.

32. The system of claim 28, wherein the processor is further configured to, after the processor determines a condition of the target tissue in each of the first set of field areas based on the combined determined characteristics of the respective field areas, divide the target tissue into a second set of field areas, different from the first set of field areas;

determine characteristics of the returned electromagnetic radiation in each of said second set of field areas using said at least two spectroscopic methods, combine the characteristics determined by each of said at least two spectroscopic methods for each of said second set of field areas and determine a condition of the target tissue in each of the second set of field areas based on the combined determined characteristics of the respective field areas.

33. The system of claim 27, wherein the device that senses electromagnetic radiation is movable to a plurality of pre-determined positions and is configured to sense electromagnetic radiation returned from a subset of the plurality of interrogation points at each pre-determined position.

34. The system of claim 19, wherein the processor is also configured to conduct a pattern recognition process to determine whether a pattern of conditions exists within the target tissue.

35. The system of claim 19, wherein the processor is also configured to create a map of determined conditions of different portions of a target tissue.

58. The system according to claim 19, wherein the processor makes fluorescence and scattering or reflective measurements at two wavelengths at each of a plurality of interrogation points, determines a fluorescence ratio for the fluorescence measurements taken at the two wavelengths at each of the plurality of interrogation points and averages the fluorescence ratios, and determines a scattering or reflectance ratio for the scattering or reflectance measurements taken at the two wavelengths at each of the plurality of interrogation points and averages the scattering or reflectance ratios.

59. The system of claim 58, wherein the processor determines the condition of the target tissue based on the averaged fluorescence and scattering or reflectance ratios.

60. The system of claim 58, wherein the target tissue is divided into quadrants and the plurality of interrogation points are distributed over a respective quadrant.

61. The system of claim 60, wherein the processor repeats the functions of claim 58 for each quadrant.

62. The system of claim 58, wherein the plurality of interrogation points are distributed over the surface area of the target tissue.

63. The system of claim 58, wherein the target tissue is divided into a plurality of field areas and the plurality of interrogation points are distributed over a respective field area.

65. The system of claim 19, wherein the processor makes fluorescence and scattering or reflectance measurements at two wavelengths at each of a plurality of interrogation points, determines a fluorescence ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points, averages the fluorescence ratios, determines a coefficient of variation value for the averaged fluorescence ratio, determines a scattering or reflectance ratio for the measurements taken at the two wavelengths at each of the plurality of interrogation points, averages the scattering or reflectance ratios and determines a coefficient of variation value for the averaged scattering or reflectance ratio.

66. The system of claim 65, wherein the processor determines the condition of the target tissue based upon the coefficient of variation values for the averaged fluorescence and scattering or reflectance ratios.

67. The system of claim 65, wherein the target tissue is divided into quadrants and the plurality of interrogation points are distributed over a respective quadrant.

68. The system of claim 67, wherein the processor repeats the functions of claim 63 for each quadrant.

69. The system of claim 65, wherein the plurality of interrogation points are distributed over the surface area of the target tissue.

70. The system of claim 65, wherein the target tissue is divided into a plurality of field areas and the plurality of interrogation points are distributed over a respective field area.

71. The system of claim 70, wherein the processor repeats the functions of claim 65 for each of the plurality of field areas.

72. The system of claim 65, wherein the processor compares the coefficient of variation values to coefficient of variation values previously determined for other target tissue.

73. The system of claim 72, wherein the other target tissue comprises target tissue belonging to other patients.

80. The system of claim 19, wherein the processor determines whether the target tissue shows signs of dysplasia or metaplasia.

36. A method for diagnosing diseased tissue in a human or animal, comprising:

irradiating a target tissue with excitation electromagnetic radiation;

sensing a returned electromagnetic radiation returned from the target tissue;

determining characteristics of the returned electromagnetic radiation using at least two spectroscopic methods, thereby decoupling and detecting biochemical changes and morphological changes in the target tissue occurring due to disease; and

determining a condition of the target tissue based the determined characteristics.

81. The method of claim 36, wherein the step of determining a condition of the target tissue based on the combined determined characteristics comprises determining whether the target tissue shows signs of dysplasia or metaplasia.

37. A system for determining a condition of a target tissue in a human or animal, comprising:

an electromagnetic radiation source for providing excitation electromagnetic radiation;

a device that couples the excitation electromagnetic radiation to a target tissue;

a device that senses electromagnetic radiation returned from the target tissue; and

a processor configured to determine characteristics of the returned electromagnetic radiation using at least two spectroscopic methods, thereby decoupling and detecting biochemical changes and morphological changes in the target tissue occurring due to disease and determine a condition of the target tissue based on the determined characteristics.

82. The system of claim 37, wherein the processor determines whether the target tissue shows signs of dysplasia or metaplasia.